
Sign up to save your podcasts
Or


Dr. Bradley Ong discusses evidence for candesartan in migraine prevention.
Show citation:
Øie LR, Wergeland T, Salvesen Ø, et al. Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2025;24(10):817-827. doi:10.1016/S1474-4422(25)00269-8
By American Academy of Neurology4.8
132132 ratings
Dr. Bradley Ong discusses evidence for candesartan in migraine prevention.
Show citation:
Øie LR, Wergeland T, Salvesen Ø, et al. Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2025;24(10):817-827. doi:10.1016/S1474-4422(25)00269-8

319 Listeners

506 Listeners

298 Listeners

50 Listeners

299 Listeners

3,360 Listeners

13 Listeners

1,152 Listeners

24 Listeners

197 Listeners

93 Listeners

517 Listeners

373 Listeners

188 Listeners

84 Listeners